- Home
- CYCU vs PRPH Comparison
CYCU vs PRPH Comparison
Compare CYCU & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCU
- PRPH
- Stock Information
- Founded
- CYCU N/A
- PRPH 1989
- Country
- CYCU United States
- PRPH United States
- Employees
- CYCU N/A
- PRPH N/A
- Industry
- CYCU
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- CYCU
- PRPH Health Care
- Exchange
- CYCU Nasdaq
- PRPH Nasdaq
- Market Cap
- CYCU 13.1M
- PRPH 14.5M
- IPO Year
- CYCU N/A
- PRPH 1997
- Fundamental
- Price
- CYCU $0.18
- PRPH $0.38
- Analyst Decision
- CYCU
- PRPH
- Analyst Count
- CYCU 0
- PRPH 0
- Target Price
- CYCU N/A
- PRPH N/A
- AVG Volume (30 Days)
- CYCU 36.4M
- PRPH 15.6M
- Earning Date
- CYCU 08-13-2025
- PRPH 08-13-2025
- Dividend Yield
- CYCU N/A
- PRPH N/A
- EPS Growth
- CYCU N/A
- PRPH N/A
- EPS
- CYCU N/A
- PRPH N/A
- Revenue
- CYCU $16,285,283.00
- PRPH $5,588,000.00
- Revenue This Year
- CYCU N/A
- PRPH $221.82
- Revenue Next Year
- CYCU N/A
- PRPH N/A
- P/E Ratio
- CYCU N/A
- PRPH N/A
- Revenue Growth
- CYCU N/A
- PRPH N/A
- 52 Week Low
- CYCU $0.17
- PRPH $0.22
- 52 Week High
- CYCU $10.99
- PRPH $2.97
- Technical
- Relative Strength Index (RSI)
- CYCU N/A
- PRPH 57.28
- Support Level
- CYCU N/A
- PRPH $0.28
- Resistance Level
- CYCU N/A
- PRPH $0.35
- Average True Range (ATR)
- CYCU 0.00
- PRPH 0.03
- MACD
- CYCU 0.00
- PRPH 0.01
- Stochastic Oscillator
- CYCU 0.00
- PRPH 74.02
About CYCU Cycurion Inc. Common Stock
Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.